EICHORCondition: Angioplasty, Balloon · Sponsor: University Hospital, Bordeaux
The aim of this multicenter triple-arm randomized study is to compare two innovative techniques with the gold standard currently used and providing unsatisfactory results for the In-Stent Restenosis (ISR) treatment in femoro-popliteal arteries. This protocol compares the use of drug-coated balloons (paclitaxel - antimitotic) used alone or in association with the Excimer Laser to recalibrate the vessel lumen into the stent by destroying the whole fibrous material to the standard angioplasty using plain balloons. INTACT study main objective is to assess cost-effectiveness ratio of the treatment of femoropopliteal artery in-stent restenosis by comparing these two innovative strategies and the standard one in terms of cost per Qaly (Quality adjusted life-years) gained at 18 months from a collective perspective.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Clinique Rhône Durance | Avignon, France | — |
| Centre Hospitalier Universitaire de Besançon | Besançon, France | — |
| University Hospital of Bordeaux - Hospital Pellegrin | Bordeaux, France | — |
| Centre Hospitalier Universitaire de Clermont-Ferrand | Clermont-Ferrand, France | — |
| Centre Hospitalier Universitaire de Dijon | Dijon, France | — |
| Hospices Civils de Lyon | Lyon, France | — |
| Centre Hospitalier Universitaire de Nantes | Nantes, France | — |
| Polyclinique Les Fleurs | Ollioules, France | — |
| Hôpital Européen Georges Pompidou - AP-HP de Paris | Paris, France | — |
| Clinique de L'Europe | Rouen, France | — |
| Centre Hospitalier Universitaire de St Etienne | Saint-Etienne, France | — |
| Centre Hospitalier Universitaire de Strasbourg | Strasbourg, France | — |
+ 1 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02599389